Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed rule

Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register July 25, 2025. Document 2025-14022. Updated Nov. 21, 2026.

What it does

The Drug Enforcement Administration proposes placing clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam and their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These five substances were temporarily scheduled in an order dated July 26, 2023, and subsequently extended until July 26, 2026, pursuant to an extension published elsewhere in this issue of the Federal Register. This action will also enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these five specific controlled substances.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What it would change

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 1308

What happens next and when

Comments must be submitted electronically or postmarked on or before August 25, 2025.

The agency's dates, word for word.

Document number2025-14022
ActionNotice of proposed rulemaking.
AgenciesJustice Department; Drug Enforcement Administration
PublishedJuly 25, 2025
Comments closeAug. 25, 2025
DocketDEA-2022-0145

Source: the Federal Register (public domain). The document in the Federal Register